Approaching a scientific consensus on the association between allergies and glioma risk: A report from the glioma international case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 2, 2016, Pages 282-290

  Amirian, E Susan ^a   Zhou, Renke ^a   Wrensch, Margaret R ^b   Olson, Sara H ^c   Scheurer, Michael E ^a   Il'Yasova, Dora ^d,e   Lachance, Daniel ^f   Armstrong, Georgina N ^a   Mccoy, Lucie S ^b   Lau, Ching C ^a   Claus, Elizabeth B ^g   Barnholtz Sloan, Jill S ^h   Schildkraut, Joellen ^e   Ali Osman, Francis ^e   Sadetzki, Siegal ^i,j   Johansen, Christoffer ^k,l   Houlston, Richard S ^m   Jenkins, Robert B ^f   Bernstein, Jonine L ^c   Merrell, Ryan T ⁿ   Davis, Faith G ^o   Lai, Rose ^p   Shete, Sanjay ^q   Amos, Christopher I ^r   Melin, Beatrice S ^s   Bondy, Melissa L ^a   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f MAYO CLINIC CANCER CENTER   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^j TEL AVIV UNIVERSITY   (Israel)

^k INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^o UNIVERSITY OF ALBERTA   (Canada)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^r DARTMOUTH MEDICAL SCHOOL   (United States)

^s UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CONSENSUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECZEMA; FEMALE; GLIOMA; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MIDDLE AGED; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; BRAIN NEOPLASMS; HYPERSENSITIVITY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CONSENSUS; FEMALE; GLIOMA; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84957806090     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0847     Document Type: Article

References (47)

1. Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol 2011;18:387-95.
2. Linos E, Raine T, Alonso A, Michaud D. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 2007;99:1544-50.
3. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 2003;106:423-8.
4. Turner MC. Epidemiology: allergy history, IgE, and cancer. Cancer Immunol Immunother 2012;61:1493-510.
5. Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer 2006;118:3124-32.
6. Merrill RM, Isakson RT, Beck RE. The associationbetweenallergiesandcancer: what is currently known? Ann Allergy Asthma Immunol 2007;99:102-16.
7. Zhao H, Cai W, Su S, Zhi D, Lu J, Liu S. Allergic conditions reduce the risk of glioma: a meta-analysis based on 128, 936 subjects. Tumour Biol 2014;35: 3875-80.
8. Hemminki K, Forsti A, Fallah M, Sundquist J, Sundquist K, Ji J. Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis. Int J Cancer 2014;135:2397-403.
9. Gousias K, Markou M, Arzoglou V, Voulgaris S, Vartholomatos G, Kostoula A, et al. Frequent abnormalities of the immune system in gliomas and correlationwith theWHOgrading system of malignancy. J Neuroimmunol 2010;226:136-42.
10. Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J, et al. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol 2009;24:433-40.
11. Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004;64: 8468-73.
12. Turner MC, Krewski D, Armstrong BK, Chetrit A, Giles GG, Hours M, et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, andNew Zealand. Cancer Causes Control 2013;24:949-60.
13. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 2011;174:574-81.
14. Krishnamachari B, Il'yasova D, Scheurer ME, Bondy M, Zhou R, Wrensch M, et al. A pooledmultisite analysis of the effects of atopicmedical conditions in glioma risk in different ethnic groups. Ann Epidemiol 2015;25:270-4.
15. Schlehofer B, Siegmund B, Linseisen J, Schuz J, Rohrmann S, Becker S, et al. Primary brain tumours and specific serum immunoglobulin E: a case- control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy 2011;66:1434-41.
16. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 2012;104:1251-9.
17. McCarthy BJ, Rankin K, Il'yasova D, Erdal S, Vick N, Ali-Osman F, et al. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev 2011;20:370-8.
18. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer 2006;119:2165-72.
19. Il'yasova D, McCarthy B, Marcello J, Schildkraut JM, Moorman PG, Krishnamachari B, et al. Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls. Cancer Epidemiol Biomarkers Prev 2009;18:1232-8.
20. Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, et al. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 2009;125:680-7.
21. Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, et al. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst 2011;103:1588-95.
22. Zhou M, Wiemels JL, Bracci PM, Wrensch MR, McCoy LS, Rice T, et al. Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma. Cancer Res 2010;70: 7534-42.
23. Amirian E, Liu Y, Scheurer ME, El-Zein R, Gilbert MR, Bondy ML. Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol 2010;12:444-52.
24. Backes DM, Siddiq A, Cox DG, Calboli FC, Gaziano JM, Ma J, et al. Singlenucleotide polymorphisms of allergy-related genes and risk of adult glioma. J Neurooncol 2013;113:229-38.
25. Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, Feychting M, et al. Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 2010;171:1165-73.
26. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007;16:1229-35.
27. Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, et al. Allergic conditions and brain tumor risk. Am J Epidemiol 2007; 166:941-50.
28. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
29. Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H, et al. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 2005;65:6459-65.
30. Janeway CA, Travers P, Walport M. Immunobiology: The immunesystem in health and disease. 5th ed. New York: Garland Science; 2001.
31. Montoro J, Sastre J, Bartra J, del Cuvillo A, Davila I, Jauregui I, et al. Effect of H1 antihistamines upon the central nervous system. J Investig Allergol Clin Immunol 2006;16 Suppl 1:24-8.
32. Tonelli LH, Postolache TT. Airborne inflammatory factors: "from the nose to the brain." Front Biosci 2010;2:135-52.
33. Djupesland PG, Mahmoud RA, Messina JC. Accessing the brain: The nose may know the way. J Cereb Blood Flow Metab 2013;33:793-4.
34. Amirian ES, Armstrong GN, Zhou R, Lau CC, Claus EB, Barnholtz-Sloan JS, et al. The Gliogene Consortium: a report from the Glioma International Case-Control Study (GICC). Am J Epidemiol. In press.
35. Deckert S, Kopkow C, Schmitt J. Nonallergic comorbidities of atopic eczema: an overview of systematic reviews. Allergy 2014;69:37-45.
36. Davis FG, Al-Alem U. Allergies and adult gliomas: cohort results strengthen evidence for a causal association. J Natl Cancer Inst 2011;103:1562-3.
37. Martin M. Research reinforces potential allergies-glioma connection. J Natl Cancer Inst 2012;104:353-6.
38. Scheurer ME, Amirian ES, Davlin SL, Rice T, Wrensch M, Bondy ML. Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer 2011;129:2290-6.
39. Scheurer ME, El-Zein R, Thompson PA, Aldape KD, Levin VA, Gilbert MR, et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev 2008;17:1277-81.
40. Amirian ES, Marquez-Do D, Bondy ML, Scheurer ME. Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. Cancer Epidemiol 2013;37:908-12.
41. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role ofmedical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155-60.
42. Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer 2002;98:609-15.
43. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, et al. AllergoOncology: The role of IgE-mediated allergy in cancer. Allergy 2008;63:1255-66.
44. Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature 2012;484:465-72.
45. Sherman PW, Holland E, Sherman JS. Allergies: Their role in cancer prevention. Q Rev Biol 2008;83:339-62.
46. Profet M. The function of allergy: immunological defense against toxins. Q Rev Biol 1991;66:23-62.
47. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010;125:S 73-80.